Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension

J Hepatol. 2005 Aug;43(2):258-65. doi: 10.1016/j.jhep.2005.02.036.

Abstract

Background/aims: Splanchnic arterial vasodilation in portal hypertension has been attributed largely to vascular NO overproduction. Three NO-synthase (NOS) isoforms have been identified of which e(ndothelial)-NOS has been found up-regulated and i(nducible)-NOS not expressed in the splanchnic circulation in portal hypertension. So far, n(euronal)-NOS has not been investigated and hence, the current study evaluates nNOS-expression and nNOS-mediated vasorelaxation in a model of portal vein-ligated rats (PVL).

Methods: Mesenteric vasculature of PVL and sham rats was evaluated for nNOS-protein (immunohistochemically and Western blotting). In vitro perfused de-endothelialized mesenteric arterial vasculature was pre-constricted with norepinephrine (EC(80)) and tested for nNOS-mediated vasorelaxation by periarterial nerve stimulation (PNS, 2-12 Hz, 45V) before and after incubation with the NOS-inhibitor L-NAME (10(-4)M).

Results: nNOS was localized to the adventitia of the mesenteric arterial tree showing more intense staining and increased protein expression in PVL as compared to sham rats. PNS induced a frequency-dependent vasorelaxation, which was more pronounced in PVL rats. L-NAME abolished this difference in nerval-mediated vasorelaxation, the effect being significantly greater in PVL than in sham animals.

Conclusions: Perivascular nNOS-protein expression is enhanced in mesenteric arteries in portal hypertension mediating an increased nerval NO-mediated vasorelaxation. This nNOS-derived NO overproduction may play an important role in the pathogenesis of arterial vasodilation in portal hypertension.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / pathology
  • Enzyme Inhibitors / pharmacology*
  • Hypertension, Portal / enzymology*
  • Hypertension, Portal / physiopathology
  • Immunohistochemistry
  • Male
  • Mesenteric Artery, Superior / drug effects
  • Mesenteric Artery, Superior / enzymology
  • Mesenteric Artery, Superior / pathology
  • Mesenteric Artery, Superior / physiopathology*
  • NG-Nitroarginine Methyl Ester / pharmacology*
  • Nerve Tissue Proteins / biosynthesis*
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase / biosynthesis*
  • Nitric Oxide Synthase Type I
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*
  • Vasodilation* / drug effects
  • Vasodilation* / physiology

Substances

  • Enzyme Inhibitors
  • Nerve Tissue Proteins
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nos1 protein, rat
  • NG-Nitroarginine Methyl Ester